This document is an excerpt from the EUR-Lex website
Document C2007/082/104
Case T-47/07: Action brought on 21 February 2007 — ratiopharm GmbH v OHIM (BioGeneriX)
Case T-47/07: Action brought on 21 February 2007 — ratiopharm GmbH v OHIM (BioGeneriX)
Case T-47/07: Action brought on 21 February 2007 — ratiopharm GmbH v OHIM (BioGeneriX)
OJ C 82, 14.4.2007, p. 50–50
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, RO, SK, SL, FI, SV)
|
14.4.2007 |
EN |
Official Journal of the European Union |
C 82/50 |
Action brought on 21 February 2007 — ratiopharm GmbH v OHIM (BioGeneriX)
(Case T-47/07)
(2007/C 82/104)
Language of the case: German
Parties
Applicant: ratiopharm GmbH (Ulm, Germany) (represented by Rechtsanwalt S. Völker)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)
Form of order sought
|
— |
Annul the decision of the Fourth Board of Appeal of the Office for Harmonisation in the Internal Market of 20 December 2006 in appeal No. R1047/2004-4 concerning Community trade mark application No. 001701762. |
|
— |
Order the Office for Harmonisation in the Internal Market to pay its own costs. |
Pleas in law and main arguments
Community trade mark concerned: the word mark BioGeneriX for goods and services in the classes 5, 35, 40 and 42 (Application No. 1 701 762).
Decision of the Examiner: Refusal to register.
Decision of the Board of Appeal: Rejection of the appeal.
Pleas in law: Infringement of Article 7(1)(b) and (c) of Regulation (EC) No. 40/94 (1), on the basis that the trade mark applied for demonstrates the minimum distinctive character required and that there is no specific need for availability.
(1) Council Regulation No. 40/94 of 20 December 1993 on the Community trade mark (OJ 1994, L 11, p. 1).